These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38539479)

  • 61. Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors.
    Wang J; Zhu N; Su X; Yang R
    Cancer Lett; 2024 Feb; 582():216582. PubMed ID: 38065401
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review.
    Sun C; Zhu D; Zhu Q; He Z; Lou Y; Chen D
    Front Cell Infect Microbiol; 2024; 14():1337223. PubMed ID: 38404291
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids.
    Li JM; Yu R; Zhang LP; Wen SY; Wang SJ; Zhang XY; Xu Q; Kong LD
    Microbiome; 2019 Jun; 7(1):98. PubMed ID: 31255176
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fermented Bamboo Fiber Improves Productive Performance by Regulating Gut Microbiota and Inhibiting Chronic Inflammation of Sows and Piglets during Late Gestation and Lactation.
    Sun C; Song R; Zhou J; Jia Y; Lu J
    Microbiol Spectr; 2023 Jun; 11(3):e0408422. PubMed ID: 37042787
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy.
    Das S; Ciombor KK; Haraldsdottir S; Pumpalova Y; Sahin IH; Pineda G; Shyr Y; Lin EP; Hsu CY; Chu SK; Goff LW; Cardin DB; Bilen MA; Fisher GA; Wu C; Berlin J
    Oncologist; 2020 Aug; 25(8):669-679. PubMed ID: 31943525
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The gut wall's potential as a partner for precision oncology in immune checkpoint treatment.
    Hone Lopez S; Jalving M; Fehrmann RSN; Nagengast WB; de Vries EGE; de Haan JJ
    Cancer Treat Rev; 2022 Jun; 107():102406. PubMed ID: 35569388
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
    Miao K; Zhang X; Wang H; Si X; Ni J; Zhong W; Zhao J; Xu Y; Chen M; Pan R; Wang M; Zhang L
    Front Immunol; 2022; 13():912180. PubMed ID: 35844502
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes.
    Barengolts E; Green SJ; Chlipala GE; Layden BT; Eisenberg Y; Priyadarshini M; Dugas LR
    Microorganisms; 2019 Sep; 7(9):. PubMed ID: 31491976
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Probiotic Lactiplantibacillus plantarum N-1 could prevent ethylene glycol-induced kidney stones by regulating gut microbiota and enhancing intestinal barrier function.
    Wei Z; Cui Y; Tian L; Liu Y; Yu Y; Jin X; Li H; Wang K; Sun Q
    FASEB J; 2021 Nov; 35(11):e21937. PubMed ID: 34606628
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characteristics of Gut Microbiome and Its Metabolites, Short-Chain Fatty Acids, in Children With Idiopathic Short Stature.
    Li L; Chen L; Yang Y; Wang J; Guo L; An J; Ma X; Lu W; Xiao Y; Wang X; Dong Z
    Front Endocrinol (Lausanne); 2022; 13():890200. PubMed ID: 35757432
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients.
    Song P; Yang D; Wang H; Cui X; Si X; Zhang X; Zhang L
    Thorac Cancer; 2020 Jun; 11(6):1621-1632. PubMed ID: 32329229
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota.
    Zhao L; Lou H; Peng Y; Chen S; Fan L; Li X
    Diabetes Res Clin Pract; 2020 Nov; 169():108418. PubMed ID: 32891692
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors.
    Nomura M; Nagatomo R; Doi K; Shimizu J; Baba K; Saito T; Matsumoto S; Inoue K; Muto M
    JAMA Netw Open; 2020 Apr; 3(4):e202895. PubMed ID: 32297948
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer.
    Katayama Y; Yamada T; Shimamoto T; Iwasaku M; Kaneko Y; Uchino J; Takayama K
    Transl Lung Cancer Res; 2019 Dec; 8(6):847-853. PubMed ID: 32010563
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Zonulin as a Potential Therapeutic Target in Microbiota-Gut-Brain Axis Disorders: Encouraging Results and Emerging Questions.
    Veres-Székely A; Szász C; Pap D; Szebeni B; Bokrossy P; Vannay Á
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108711
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Discontinuation due to immune-related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non-small cell lung cancer.
    Komiya K; Nakamura T; Abe T; Ogusu S; Nakashima C; Takahashi K; Kimura S; Sueoka-Aragane N
    Thorac Cancer; 2019 Sep; 10(9):1798-1804. PubMed ID: 31328416
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors : Antibiotics immune checkpoint inhibitors in advanced NSCLC.
    Schett A; Rothschild SI; Curioni-Fontecedro A; Krähenbühl S; Früh M; Schmid S; Driessen C; Joerger M
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):121-131. PubMed ID: 31745593
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin-10 Is a Promising Marker for Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Receiving Immunotherapy.
    Wang H; Zhou F; Zhao C; Cheng L; Zhou C; Qiao M; Li X; Chen X
    Front Immunol; 2022; 13():840313. PubMed ID: 35222434
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes.
    Maffeis C; Martina A; Corradi M; Quarella S; Nori N; Torriani S; Plebani M; Contreas G; Felis GE
    Diabetes Metab Res Rev; 2016 Oct; 32(7):700-709. PubMed ID: 26891226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.